Design, Synthesis, and Biological Evaluation of Indole Biphenylcarboxylic Acids as PPARγ Antagonists

[Image: see text] The thiazolidinediones (TZD) typified by rosiglitazone are the only approved therapeutics targeting PPARγ for the treatment of type-2 diabetes (T2DM). Unfortunately, despite robust insulin sensitizing properties, they are accompanied by a number of severe side effects including con...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:ACS Med Chem Lett
Main Authors: Asteian, Alice, Blayo, Anne-Laure, He, Yuanjun, Koenig, Marcel, Shin, Youseung, Kuruvilla, Dana S., Corzo, Cesar A., Cameron, Michael D., Lin, Li, Ruiz, Claudia, Khan, Susan, Kumar, Naresh, Busby, Scott, Marciano, David P., Garcia-Ordonez, Ruben D., Griffin, Patrick R., Kamenecka, Theodore M.
Formato: Artigo
Idioma:Inglês
Publicado em: American Chemical Society 2015
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4569877/
https://ncbi.nlm.nih.gov/pubmed/26396687
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acsmedchemlett.5b00218
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados